Beatrice Mintz
Department of Cancer Research
Fox Chase Cancer Center
United States of America
Biography
Beatrice Mintz (born January 24, 1921 in New York City)is an American embryologist who has contributed to the understanding of genetic modification, cellular differentiation and cancer, particularly melanoma. Mintz was a pioneer of genetic engineering techniques, and was among the first scientists to generate both chimeric and transgenic mammals.
Research Interest
Cutaneous melanoma. transgene DNA. genetically modified mammals
Publications
-
Milling, S. W., Sai, T., Silvers, W. K., & Mintz, B. (2004). Inhibition of melanoma growth after treatment with dendritic cells in a Tyr-SV40E murine model requires CD4+ T cells but not CD8+ T cells. Melanoma research, 14(6), 555-562.
-
Blelloch, R. H., Hochedlinger, K., Yamada, Y., Brennan, C., Kim, M., Mintz, B., ... & Jaenisch, R. (2004). Nuclear cloning of embryonal carcinoma cells. Proceedings of the National Academy of Sciences of the United States of America, 101(39), 13985-13990.
-
Mintz, B., & Silvers, W. K. (1967). " Intrinsic" immunological tolerance in allophenic mice. Science, 158(3807), 1484-1487.
